Loading…
Check-Cap Ltd. is projected to rise to $1.68 by 2027, a +38% move from its current price of $1.22. MBAI is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.16 | $1.22 | $1.28 | -0.02% |
| Jul 14 | $1.14 | $1.22 | $1.31 | -0.05% |
| Jul 15 | $1.12 | $1.22 | $1.33 | -0.07% |
| Jul 16 | $1.10 | $1.22 | $1.35 | -0.10% |
| Jul 17 | $1.09 | $1.22 | $1.36 | -0.12% |
| Jul 18 | $1.08 | $1.22 | $1.38 | -0.14% |
| Jul 19 | $1.07 | $1.22 | $1.39 | -0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.07 | $1.22 | $1.39 | -0.17% |
| Week 2 | $1.01 | $1.22 | $1.46 | -0.33% |
| Week 3 | $0.967 | $1.21 | $1.52 | -0.50% |
| Week 4 | $0.932 | $1.21 | $1.58 | -0.66% |
| Week 5 | $0.902 | $1.21 | $1.62 | -0.83% |
| Week 6 | $0.8756 | $1.21 | $1.67 | -0.99% |
| Week 7 | $0.8519 | $1.21 | $1.71 | -1.16% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps.
Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.
It is categorized in Healthcare.
MBAI is trading at $1.23 per share. The current price is $1.23 and the market cap is $9.51M, with a rank of 5152 in market capitalization.
A major floor 42.6% below — a decisive break under it would weaken the trend.
The nearest floor, 10.7% below — buyers have tended to step in here.
The nearest ceiling, 42.6% above — a clean break opens room to run.
A major ceiling 63.9% above — clearing it would confirm fresh momentum.
Key MBAI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MBAI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.18 | Buy | $1.20 | Buy |
| MA 10 | $1.19 | Buy | $1.21 | Buy |
| MA 20 | $1.27 | Sell | $1.27 | Sell |
| MA 50 | $1.47 | Sell | $1.42 | Sell |
| MA 100 | $1.58 | Sell | $1.52 | Sell |
| MA 200 | $1.67 | Sell | $1.52 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.45 | Neutral |
| Stoch RSI (14) | 95.99 | Sell |
| CCI (20) | -33.03 | Neutral |
| Williams %R (14) | -59.37 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -10.29 | Sell |
| Bollinger %B (20,2) | 0.39 | Neutral |
| Stochastic %K (14) | 40.63 | Neutral |
| TRIX (15) | -1.03 | Sell |
| Awesome (5,34) | -0.23 | Sell |
| Ultimate (7,14,28) | 41.47 | Neutral |
| Momentum (10) | 0.11 | Buy |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 1.18 | Buy |
| ADX (14) | 19.55 | Neutral |
| ATR (14) | 0.06 | Info |
The 30-day technical picture is NEUTRAL. RSI(14) is 40, with a SMA50 of $1.48 and a SMA200 of $1.68.
The 30-day range spans from $0.8777 to $1.72. Support sits at $1.09 and resistance at $1.74.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.09 | $1.22 | $1.86 | 0% | Neutral | |
| $1.24 | $1.68 | $2.47 | +38% | Bullish | |
| $1.40 | $2.01 | $3.13 | +65% | Bullish | |
| $1.22 | $1.83 | $2.99 | +50% | Bullish | |
| $1.16 | $1.83 | $3.11 | +50% | Bullish | |
| $1.09 | $1.78 | $3.11 | +46% | Bullish | |
| $0.9103 | $1.55 | $2.79 | +27% | Bullish | |
| $1.05 | $1.85 | $3.42 | +52% | Bullish | |
| $1.31 | $2.39 | $4.54 | +96% | Bullish | |
| $1.38 | $2.61 | $5.07 | +114% | Bullish | |
| $1.23 | $2.74 | $5.82 | +125% | Bullish | |
| $2.15 | $4.77 | $10.96 | +291% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.09 | $1.22 | $1.51 | +0.00% |
| August 2026 | $1.05 | $1.27 | $1.59 | +3.82% |
| September 2026 | $0.9761 | $1.19 | $1.53 | -5.75% |
| October 2026 | $0.968 | $1.20 | $1.56 | +0.28% |
| November 2026 | $1.07 | $1.33 | $1.76 | +11.50% |
| December 2026 | $1.11 | $1.40 | $1.86 | +4.70% |
Click any year to see its month-by-month MBAI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, MBAI is projected to trade between $1.09 and $1.86, averaging $1.22 — a potential gain of 0% from today's $1.22. Price action looks broadly range-bound.
Check-Cap Ltd.'s 2027 outlook centres on $1.68, within a $1.24 to $2.47 range. That is up +38% on the projected 2026 average. That marks a +38% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, MBAI could reach as high as $3.13, with a base case around $2.01 and support toward $1.40 — roughly +65% from $1.22. Momentum favours further upside here.
Expect MBAI to range from $1.22 to $2.99 through 2029. The $1.83 average target implies a +50% move from current prices. That is -9% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
The MBAI price prediction for 2030 points to an average of $1.83 (low $1.16, high $3.11) — a potential gain of +50% on today's $1.22. Momentum favours further upside here.
In 2031, MBAI is projected to trade between $1.09 and $3.11, averaging $1.78 — a potential gain of +46% from today's $1.22. That is -3% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
Check-Cap Ltd.'s 2032 outlook centres on $1.55, within a $0.9103 to $2.79 range. That is -13% versus the projected 2031 average. That marks a +27% change versus current levels. Momentum favours further upside here.
By 2033, MBAI could reach as high as $3.42, with a base case around $1.85 and support toward $1.05 — roughly +52% from $1.22. Buyers look set to stay in control over this stretch.
Expect MBAI to range from $1.31 to $4.54 through 2034. The $2.39 average target implies a +96% move from current prices. That is up +29% on the projected 2033 average. Momentum favours further upside here.
The MBAI price prediction for 2035 points to an average of $2.61 (low $1.38, high $5.07) — a potential gain of +114% on today's $1.22. Buyers look set to stay in control over this stretch.
In 2040, MBAI is projected to trade between $1.23 and $5.82, averaging $2.74 — a potential gain of +125% from today's $1.22. That is up +5% on the projected 2035 average. Momentum favours further upside here.
Check-Cap Ltd.'s 2050 outlook centres on $4.77, within a $2.15 to $10.96 range. That is up +74% on the projected 2040 average. That marks a +291% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in MBAI today (≈ 819.672131 MBAI) could be worth
$3,907.17
+$2,907.17 (+291%) by 2050 · US Dollar
Based on the average projected MBAI price of $4.77 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MBAIwould be worth at today's price.
$1,000 invested in MBAI on Jul 10, 2025 (≈ 1,280.409701 MBAI) would be worth
$1,562.1
+$562.1 (+56.2%) today · 1.56× · US Dollar
Based on a MBAI entry price of $0.781 vs. today's $1.22.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.14 | $1,070.18 | +7.0% |
| 1 month ago | $1.33 | $917.29 | -8.3% |
| 3 months ago | $1.68 | $726.19 | -27.4% |
| 6 months ago | $1.68 | $726.19 | -27.4% |
| 1 year ago | $0.781 | $1,562.1 | +56.2% |
| All time (5.0y) ago | $22.2 | $54.95 | -94.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MBAI forecast.
Our base-case forecast reaches $2.40 around 2035.
Implied market cap at $2.40: $18.55M
The multi-year forecast carries a bullish tone from 2027 onward. The year-by-year outlook shows rising averages through the period, with 2027 avg $1.74 and 2028 avg $2.07, and 2030 avg $1.88. By 2040 the forecast avg is $2.91 and by 2050 it is $4.99.
Across the horizon, a path to higher values is shown, with 2040 max $6.27 and 2050 max $11.48. Notable figures include 2030 ROI 53, 2040 ROI 136.8, and 2050 ROI 305.7, all labeled BULLISH.
These are estimates of future prices and are not guarantees.
Tap a question to reveal the answer.
2030 min $1.18, avg $1.88, max $3.22, ROI 53, sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward, with 2027 avg $1.74 and 2050 avg $4.99 and ROI up to 305.7, but 2026 shows min $1.09, avg $1.23, max $1.91 and ROI 0.
Yes, the 2050 max is $11.48, with 2050 avg $4.99 and min $2.25; sentiment is BULLISH.
Sentiment NEUTRAL; RSI14 40; SMA50 $1.48; SMA200 $1.68; support $1.09; resistance $1.74; 30-day range $0.8777-$1.72.
Current price $1.23; Market cap $9.51M; Rank 5152.
Check-Cap Ltd. Community Discussion
0Share your Check-Cap Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.